ID=wsj_1246.1 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N CD CD Two N_140/N_140>) (<T N 1 2> (<L N/N JJ JJ Japanese N_133/N_133>) (<L N NNS NNS scientists N>) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_8)/S[dcl]_9>) (<T S[dcl] 1 2> (<L NP PRP PRP they NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD discovered (S[dcl]\NP_16)/NP_17>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT an NP[nb]_24/N_24>) (<L N NN NN antibody N>) ) (<T NP\NP 0 2> (<T (NP\NP)/(S[dcl]\NP) 0 2> (<L (NP\NP)/(S[dcl]\NP) IN IN that (NP_34\NP_34)/(S[dcl]_35\NP_34:B)_35>) (<L , , , , ,>) ) (<T S[dcl]\NP 1 2> (<T (S\NP)/(S\NP) 0 2> (<L ((S\NP)/(S\NP))/NP IN IN in ((S_104\NP_99)_104/(S_104\NP_99)_104)/NP_105>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN laboratory N_121/N_121>) (<T N 1 2> (<L N/N NN NN test-tube N_114/N_114>) (<L N NNS NNS experiments N>) ) ) ) ) (<T S[dcl]\NP 1 2> (<L , , , , ,>) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ kills (S[dcl]\NP_44)/NP_45>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ AIDS-infected N_54/N_54>) (<L N NNS NNS cells N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/(S[ng]\NP) IN IN while ((S_70\NP_63)_70\(S_70\NP_63)_70)/(S[ng]_71\NP_63:B)_71>) (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/NP VBG VBG preserving (S[ng]\NP_78)/NP_79>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ healthy N_88/N_88>) (<L N NNS NNS cells N>) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.2 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S/S 0 2> (<L (S/S)/S[dcl] IN IN If (S_215/S_215)/S[dcl]_216>) (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ further N_240/N_240>) (<L N NNS NNS experiments N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[adj]\NP) VBP VBP are (S[dcl]\NP_225)/(S[adj]_226\NP_225:B)_226>) (<L S[adj]\NP JJ JJ successful S[adj]\NP_231>) ) ) ) (<T S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_205/N_205>) (<L N NN NN work N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD would (S[dcl]\NP_130)/(S[b]_131\NP_130:B)_131>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB represent (S[b]\NP_138)/NP_139>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_153/N_153>) (<T N 1 2> (<L N/N JJ JJ major N_148/N_148>) (<L N NN NN advance N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_161\NP_161)/NP_162>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN research N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN on (NP_173\NP_173)/NP_174>) (<T NP 0 1> (<T N 1 2> (<L N/N VBN VBN acquired N_197/N_197>) (<T N 1 2> (<L N/N JJ JJ immune N_190/N_190>) (<T N 1 2> (<L N/N NN NN deficiency N_183/N_183>) (<L N NN NN syndrome N>) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.3 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_223/N_223>) (<T N 1 2> (<L N/N NN NN drug N_218/N_218>) (<L N NNP NNP AZT N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_237/N_237>) (<T N 1 2> (<L N/N JJ JJ only N_232/N_232>) (<L N NN NN treatment N>) ) ) (<T NP\NP 1 2> (<L (NP\NP)/(NP\NP) RB RB currently (NP_267\NP_261)_267/(NP_267\NP_261)_267>) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN on (NP_245\NP_245)/NP_246>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_253/N_253>) (<L N NN NN market N>) ) ) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[to]\NP) VBZ VBZ claims (S[dcl]\NP_115)/(S[to]_116\NP_115:B)_116>) (<T S[to]\NP 0 2> (<T S[to]\NP 1 2> (<L (S\NP)/(S\NP) RB RB only (S_175\NP_170)_175/(S_175\NP_170)_175>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_125)/(S[b]_126\NP_125:B)_126>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[b]\NP) VB VB help (S[b]\NP_135)/(S[b]_136\NP_135:B)_136>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB stop (S[b]\NP_143)/NP_144>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_151/N_151>) (<L N NN NN spread N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_159\NP_159)/NP_160>) (<T NP 0 1> (<L N NNP NNP AIDS N>) ) ) ) ) ) ) ) (<T S[to]\NP[conj] 1 2> (<L , , , , ,>) (<T S[to]\NP 1 2> (<L (S\NP)/(S\NP) RB RB not (S_207\NP_202)_207/(S_207\NP_202)_207>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_184)/(S[b]_185\NP_184:B)_185>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB cure (S[b]\NP_192)/NP_193>) (<L NP PRP PRP it NP>) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.4 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L S/S CC CC But S_324/S_324>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ several N_198/N_198>) (<L N NNS NNS analysts N>) ) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ Japanese N_208/N_208>) (<L N NNS NNS scientists N>) ) ) ) ) (<T NP\NP 0 1> (<T S[adj]\NP 0 2> (<L S[adj]\NP JJ JJ familiar S[adj]\NP_216>) (<T (S[adj]\NP)\(S[adj]\NP) 0 2> (<L ((S[adj]\NP)\(S[adj]\NP))/NP IN IN with ((S[adj]_229\NP_224)_229\(S[adj]_229\NP_224)_229)/NP_230>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_237/N_237>) (<L N NN NN study N>) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT which (NP_249\NP_249)/(S[dcl]_250\NP_249:B)_250>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pss]\NP) VBD VBD was (S[dcl]\NP_259)/(S[pss]_260\NP_259:B)_260>) (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN announced S[pss]\NP_265>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN at ((S_278\NP_273)_278\(S_278\NP_273)_278)/NP_279>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_286/N_286>) (<L N NN NN conference N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_294\NP_294)/NP_295>) (<T NP 0 1> (<L N NNP NNP Nagoya N>) ) ) ) ) ) (<L (S\NP)\(S\NP) NN NN yesterday (S_310\NP_305)_310\(S_310\NP_305)_310>) ) ) ) ) (<L , , , , ,>) ) ) ) ) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/PP 0 2> (<L ((S[dcl]\NP)/PP)/NP VBD VBD expressed ((S[dcl]\NP_156)/PP_157)/NP_158>) (<T NP 0 1> (<L N NN NN skepticism N>) ) ) (<T PP 0 2> (<L PP/NP IN IN over PP/NP_166>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_173/N_173>) (<L N NN NN significance N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_181\NP_181)/NP_182>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_189/N_189>) (<L N NNS NNS results N>) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.5 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L S/S CC CC And S_311/S_311>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_297/N_297>) (<L N NNS NNS researchers N>) ) (<L NP\NP PRP PRP themselves NP_304\NP_304>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD acknowledged (S[dcl]\NP_154)/S[dcl]_155>) (<T S[dcl] 1 2> (<L NP PRP PRP they NP>) (<T S[dcl]\NP 1 2> (<L (S\NP)/(S\NP) RB RB still (S_288\NP_283)_288/(S_288\NP_283)_288>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD must (S[dcl]\NP_164)/(S[b]_165\NP_164:B)_165>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB do (S[b]\NP_172)/NP_173>) (<T NP 0 1> (<T N 1 2> (<T N/N 1 2> (<L (N/N)/(N/N) RB RB much (N_196/N_190)_196/(N_196/N_190)_196>) (<L N/N JJR JJR more N_182/N_182>) ) (<L N NN NN work N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/S[dcl] IN IN before ((S_210\NP_205)_210\(S_210\NP_205)_210)/S[dcl]_211>) (<T S[dcl] 1 2> (<L NP PRP PRP they NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD can (S[dcl]\NP_220)/(S[b]_221\NP_220:B)_221>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/S[qem] VB VB say (S[b]\NP_228)/S[qem]_229>) (<T S[qem] 0 2> (<L S[qem]/S[dcl] IN IN whether S[qem]/S[dcl]_234>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_274/N_274>) (<L N NN NN treatment N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD would (S[dcl]\NP_243)/(S[b]_244\NP_243:B)_244>) (<L (S\NP)\(S\NP) RB RB actually (S_256\NP_251)_256\(S_256\NP_251)_256>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB cure (S[b]\NP_263)/NP_264>) (<T NP 0 1> (<L N NNS NNS humans N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.6 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Shin N_303/N_303>) (<L N NNP NNP Yonehara N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_318/N_318>) (<T N 1 2> (<L N/N NN NN research N_313/N_313>) (<L N NN NN scientist N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN at (NP_326\NP_326)/NP_327>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_348/N_348>) (<T N 1 2> (<L N/N NNP NNP Tokyo N_343/N_343>) (<T N 1 2> (<L N/N NNP NNP Metropolitan N_336/N_336>) (<L N NNP NNP Institute N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_356\NP_356)/NP_357>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Medical N_366/N_366>) (<L N NNP NNP Science N>) ) ) ) ) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_158)/S[dcl]_159>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_272/N_272>) (<L N NN NN antibody N>) ) (<T NP\NP 0 1> (<T S[dcl]/NP 1 2> (<T S/(S\NP) 0 1> (<L NP PRP PRP he NP>) ) (<L (S[dcl]\NP)/NP VBD VBD discovered (S[dcl]\NP_279)/NP_280>) ) ) ) (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBZ VBZ works S[dcl]\NP_164>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/(S[ng]\NP) IN IN by ((S_179\NP_172)_179\(S_179\NP_172)_179)/(S[ng]_180\NP_172:B)_180>) (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/NP VBG VBG recognizing (S[ng]\NP_187)/NP_188>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT an NP[nb]_195/N_195>) (<L N NN NN antigen N>) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/NP VBN VBN called (S[pss]\NP_202)/NP_203>) (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_210/N_210>) (<L N NN NN Fas-antigen N>) ) ) ) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT which (NP_227\NP_227)/(S[dcl]_228\NP_227:B)_228>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[adj]\NP) VBZ VBZ is (S[dcl]\NP_237)/(S[adj]_238\NP_237:B)_238>) (<T S[adj]\NP 0 2> (<L (S[adj]\NP)/PP JJ JJ characteristic (S[adj]\NP_245)/PP_246>) (<T PP 0 2> (<L PP/NP IN IN of PP/NP_251>) (<T NP 1 2> (<L NP[nb]/N DT DT an NP[nb]_265/N_265>) (<T N 1 2> (<L N/N JJ JJ infected N_260/N_260>) (<L N NN NN cell N>) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.7 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_212/N_212>) (<L N NN NN antibody N>) ) (<T S[dcl]\NP 1 2> (<L (S\NP)/(S\NP) RB RB then (S_205\NP_200)_205/(S_205\NP_200)_205>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ kills (S[dcl]\NP_185)/NP_186>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_193/N_193>) (<L N NN NN cell N>) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.8 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_164/N_164>) (<L N NNP NNP Yonehara N>) ) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ his NP[nb]_172/N_172>) (<L N NN NN partner N>) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Nobuyuki N_181/N_181>) (<L N NNP NNP Kobayashi N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_190\NP_190)/NP_191>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Yamaguchi N_200/N_200>) (<L N NNP NNP University N>) ) ) ) ) ) ) (<L , , , , ,>) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_38)/S[dcl]_39>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ their NP[nb]_155/N_155>) (<L N NNS NNS experiments N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[em] VBD VBD showed (S[dcl]\NP_46)/S[em]_47>) (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_52>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_148/N_148>) (<L N NN NN antibody N>) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD wiped (S[dcl]\NP_59)/NP_60>) (<L (S\NP)\(S\NP) RP RP out (S_72\NP_67)_72\(S_72\NP_67)_72>) ) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT an NP[nb]_79/N_79>) (<L N NN NN average N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_87\NP_87)/NP_88>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N CD CD 60 N_97/N_97>) (<L N NN NN % N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_106\NP_106)/NP_107>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ AIDS-infected N_116/N_116>) (<L N NNS NNS cells N>) ) ) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN within ((S_130\NP_125)_130\(S_130\NP_125)_130)/NP_131>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD three N_140/N_140>) (<L N NNS NNS days N>) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.9 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S[dcl] 1 2> (<T S/S 0 2> (<L (S/S)/NP IN IN In (S_217/S_217)/NP_218>) (<T NP 0 2> (<L NP DT DT some NP>) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_228\NP_228)/NP_229>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_236/N_236>) (<L N NNS NNS experiments N>) ) ) ) ) (<T S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl] 1 2> (<L NP PRP PRP it NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD killed (S[dcl]\NP_169)/NP_170>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP/NP 1 2> (<L (NP/NP)/(NP/NP) RB RB almost (NP_205/NP_199)_205/(NP_205/NP_199)_205>) (<L NP/NP PDT PDT all NP_191/NP_191>) ) (<L NP[nb]/N DT DT the NP[nb]_184/N_184>) ) (<T N 1 2> (<L N/N JJ JJ infected N_179/N_179>) (<L N NNS NNS cells N>) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_160/N_160>) (<L N NNS NNS researchers N>) ) (<L (S[dcl]\S[dcl])\NP VBD VBD said (S[dcl]\S[dcl]_152)\NP_153>) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.10 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L S/S RB RB Meanwhile S_157/S_157>) (<T S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<T N/N 1 2> (<T (N/N)/(N/N) 1 2> (<L S[adj]\NP JJR JJR fewer S[adj]\NP_124>) (<L ((N/N)/(N/N))\(S[adj]\NP) IN IN than ((N_118/N_110)_118/(N_118/N_110)_118)\(S[adj]_119\NP_113)_119>) ) (<L N/N CD CD 10 N_102/N_102>) ) (<L N NN NN % N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_133\NP_133)/NP_134>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_148/N_148>) (<T N 1 2> (<L N/N JJ JJ healthy N_143/N_143>) (<L N NNS NNS cells N>) ) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pss]\NP) VBD VBD were (S[dcl]\NP_87)/(S[pss]_88\NP_87:B)_88>) (<L S[pss]\NP VBN VBN killed S[pss]\NP_93>) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.11 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_162/N_162>) (<L N CD CD two N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_75)/S[dcl]_76>) (<T S[dcl] 1 2> (<L NP PRP PRP they NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD must (S[dcl]\NP_85)/(S[b]_86\NP_85:B)_86>) (<T S[b]\NP 0 2> (<T S[b]\NP 1 2> (<L (S\NP)/(S\NP) RB RB still (S_123\NP_118)_123/(S_123\NP_118)_123>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB do (S[b]\NP_93)/NP_94>) (<T NP 0 1> (<T N 1 2> (<L N/N JJR JJR more N_110/N_110>) (<T N 1 2> (<L N/N NN NN laboratory N_103/N_103>) (<L N NNS NNS tests N>) ) ) ) ) ) (<T S[b]\NP[conj] 1 2> (<L , , , , ,>) (<T S[b]\NP 1 2> (<L (S\NP)/(S\NP) RB RB then (S_151\NP_146)_151/(S_151\NP_146)_151>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/PP VBN NN experiment (S[b]\NP_130)/PP_131>) (<T PP 0 2> (<L PP/NP IN IN on PP/NP_136>) (<T NP 0 1> (<L N NNS NNS animals N>) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.12 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L NP PRP PRP They NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_90)/S[dcl]_91>) (<T S[dcl] 1 2> (<L NP PRP PRP they NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[to]\NP) VBD VBD hoped (S[dcl]\NP_100)/(S[to]_101\NP_100:B)_101>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_110)/(S[b]_111\NP_110:B)_111>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<T (S[b]\NP)/PP 0 2> (<L ((S[b]\NP)/PP)/NP VB VB conduct ((S[b]\NP_120)/PP_121)/NP_122>) (<T NP 0 1> (<L N NNS NNS tests N>) ) ) (<T PP 0 2> (<L PP/NP IN IN on PP/NP_130>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ human N_139/N_139>) (<L N NNS NNS patients N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_148\NP_148)/NP_149>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_156/N_156>) (<L N NNP NNP U.S. N>) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_169\NP_164)_169\(S_169\NP_164)_169)/NP_170>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ late N_186/N_186>) (<T N 1 2> (<L N/N JJ JJ next N_179/N_179>) (<L N NN NN year N>) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.13 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP Japan N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) VBZ VBZ does (S[dcl]\NP_115)/(S[b]_116\NP_115:B)_116>) (<L (S\NP)\(S\NP) RB RB n't (S_128\NP_123)_128\(S_128\NP_123)_128>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB have (S[b]\NP_135)/NP_136>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ enough N_206/N_206>) (<T N 1 2> (<L N/N NNP NNP AIDS N_199/N_199>) (<T N 0 2> (<L N NNS NNS patients N>) (<T N\N 0 1> (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_147)/(S[b]_148\NP_147:B)_148>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB do (S[b]\NP_155)/NP_156>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ significant N_165/N_165>) (<L N NN NN experimentation N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_179\NP_174)_179\(S_179\NP_174)_179)/NP_180>) (<T NP 1 2> (<L NP[nb]/N DT DT that NP[nb]_187/N_187>) (<L N NN NN country N>) ) ) ) ) ) ) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 1 2> (<L NP PRP PRP they NP>) (<L (S[dcl]\S[dcl])\NP VBD VBD said (S[dcl]\S[dcl]_101)\NP_102>) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.14 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_200/N_200>) (<L N NN NN announcement N>) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD got (S[dcl]\NP_104)/NP_105>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ wide N_114/N_114>) (<L N NN NN exposure N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_128\NP_123)_128\(S_128\NP_123)_128)/NP_129>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_143/N_143>) (<T N 1 2> (<L N/N JJ JJ Japanese N_138/N_138>) (<L N NNS NNS media N>) ) ) ) ) (<T S[dcl]\NP[conj] 1 2> (<L , , , , ,>) (<T S[dcl]\NP[conj] 1 2> (<L conj CC CC and conj>) (<T S[dcl]\NP 1 2> (<L (S\NP)/(S\NP) RB RB even (S_189\NP_184)_189/(S_189\NP_184)_189>) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD moved (S[dcl]\NP_150)/NP_151>) (<T NP 1 2> (<L NP[nb]/N DT DT some NP[nb]_165/N_165>) (<T N 1 2> (<L N/N JJ JJ pharmaceutical N_160/N_160>) (<L N NNS NNS stocks N>) ) ) ) (<L (S\NP)\(S\NP) NN NN yesterday (S_177\NP_172)_177\(S_177\NP_172)_177>) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.15 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L S/S CC CC But S_309/S_309>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Takashi N_192/N_192>) (<L N NNP NNP Kitamura N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<L N NN NN director N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_204\NP_204)/NP_205>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_219/N_219>) (<T N 1 2> (<L N/N NN NN biology N_214/N_214>) (<L N NN NN department N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN at (NP_227\NP_227)/NP_228>) (<T NP 0 2> (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<L N NNP NNP Japan N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_244/N_244)\NP_245>) ) (<T N 1 2> (<L N/N NNP NNP National N_237/N_237>) (<L N NNP NNP Institute N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_256\NP_256)/NP_257>) (<T NP 0 1> (<L N NNP NNP Health N>) ) ) ) ) ) ) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN secretary N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_271\NP_271)/NP_272>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_296/N_296>) (<L N NN NN government N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_288/N_288)\NP_289>) ) (<T N 1 2> (<L N/N JJ JJ AIDS-research N_281/N_281>) (<L N NN NN center N>) ) ) ) ) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/S[dcl] 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_98)/S[dcl]_99>) (<L , , , , ,>) ) (<T S[dcl] 1 2> (<L NP PRP PRP I NP>) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[adj]\NP) 0 2> (<L (S[dcl]\NP)/(S[adj]\NP) VBP VBP 'm (S[dcl]\NP_110)/(S[adj]_111\NP_110:B)_111>) (<L (S\NP)\(S\NP) RB RB not (S_123\NP_118)_123\(S_123\NP_118)_123>) ) (<T S[adj]\NP 0 2> (<L (S[adj]\NP)/(S[adj]\NP) SO RB so (S[adj]_135\NP_130)_135/(S[adj]_135\NP_130)_135>) (<T S[adj]\NP 0 2> (<L (S[adj]\NP)/PP JJ JJ optimistic (S[adj]\NP_142)/PP_143>) (<T PP 0 2> (<L PP/NP IN IN of PP/NP_148>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ its NP[nb]_162/N_162>) (<T N 1 2> (<L N/N JJ JJ future N_157/N_157>) (<L N NN NN use N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_170\NP_170)/NP_171>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ therapeutic N_180/N_180>) (<L N NNS NNS methods N>) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.16 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L NP PRP PRP He NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_188)/S[dcl]_189>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT some NP[nb]_354/N_354>) (<T N 1 2> (<L N/N JJ JJ infected N_349/N_349>) (<L N NNS NNS cells N>) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD may (S[dcl]\NP_198)/(S[b]_199\NP_198:B)_199>) (<L (S\NP)\(S\NP) RB RB not (S_211\NP_206)_211\(S_211\NP_206)_211>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB have (S[b]\NP_218)/NP_219>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_233/N_233>) (<T N 1 2> (<L N/N JJ JJ relevant N_228/N_228>) (<L N NN NN antigen N>) ) ) ) ) (<T S[dcl]\NP[conj] 1 2> (<L conj CC CC and conj>) (<T S[dcl]\NP 1 2> (<L (S\NP)/(S\NP) RB RB so (S_338\NP_333)_338/(S_338\NP_333)_338>) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD would (S[dcl]\NP_242)/(S[b]_243\NP_242:B)_243>) (<L (S\NP)\(S\NP) RB RB n't (S_255\NP_250)_255\(S_255\NP_250)_255>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[pss]\NP) VB VB be (S[b]\NP_264)/(S[pss]_265\NP_264:B)_265>) (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN killed S[pss]\NP_270>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) RB RB even ((S_326\NP_318)_326\(S_319\NP_318)_319)_326/((S_326\NP_318)_326\(S_319\NP_318)_319)_326>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN after ((S_283\NP_278)_283\(S_283\NP_278)_283)/NP_284>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN exposure N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP TO TO to (NP_295\NP_295)/NP_296>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_303/N_303>) (<L N NN NN antibody N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.17 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 1 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_293/N_293>) (<L N NNS NNS results N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[to]\NP) VBP VBP seem (S[dcl]\NP_248)/(S[to]_249\NP_248:B)_249>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_258)/(S[b]_259\NP_258:B)_259>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[adj]\NP) VB VB be (S[b]\NP_268)/(S[adj]_269\NP_268:B)_269>) (<T S[adj]\NP 1 2> (<L (S[adj]\NP)/(S[adj]\NP) RB RB very (S[adj]_286\NP_281)_286/(S[adj]_286\NP_281)_286>) (<L S[adj]\NP JJ JJ premature S[adj]\NP_274>) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 0 2> (<T S[dcl]\S[dcl] 0 2> (<L (S[dcl]\S[dcl])/NP VBD VBD said (S[dcl]\S[dcl]_170)/NP_171>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Mitsuru N_180/N_180>) (<L N NNP NNP Miyata N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN editor N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_192\NP_192)/NP_193>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Nikkei N_202/N_202>) (<L N NNP NNP Biotechnology N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_231/N_231>) (<T N 1 2> (<L N/N VBG VBG leading N_226/N_226>) (<T N 1 2> (<L N/N JJ JJ Japanese N_219/N_219>) (<T N 1 2> (<L N/N NN NN industry N_212/N_212>) (<L N NN NN newsletter N>) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) ) ) 
ID=wsj_1246.18 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_193/N_193>) (<L N NNP NNP Kobayashi N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[em] VBD VBD responded (S[dcl]\NP_117)/S[em]_118>) (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_123>) (<T S[dcl] 1 2> (<L NP PRP PRP he NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD thought (S[dcl]\NP_130)/S[dcl]_131>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_182/N_182>) (<L N NN NN antibody N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD could (S[dcl]\NP_140)/(S[b]_141\NP_140:B)_141>) (<L (S\NP)\(S\NP) RB RB potentially (S_153\NP_148)_153\(S_153\NP_148)_153>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB kill (S[b]\NP_160)/NP_161>) (<T NP 1 2> (<L NP[nb]/N DT DT all NP[nb]_175/N_175>) (<T N 1 2> (<L N/N JJ JJ infected N_170/N_170>) (<L N NNS NNS cells N>) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.19 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L S/S CC CC But S_179/S_179>) (<T S[dcl] 1 2> (<T NP 0 2> (<L NP PRP PRP he NP>) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_169/N_169>) (<L N NNP NNP Yonehara N>) ) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_83)/S[dcl]_84>) (<T S[dcl] 1 2> (<L NP[thr] EX EX there NP[thr]>) (<T S[dcl]\NP[thr] 0 2> (<T (S[dcl]\NP[thr])/NP 0 2> (<L (S[dcl]\NP[thr])/NP VBD VBD were (S[dcl]\NP[thr]_91)/NP_92>) (<L (S\NP)\(S\NP) RB RB still (S_104\NP_99)_104\(S_104\NP_99)_104>) ) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ several N_113/N_113>) (<L N NNS NNS uncertainties N>) ) ) (<L , , , , ,>) ) (<T NP\NP 1 2> (<L (NP\NP)/(NP\NP) RB RB particularly (NP_156\NP_150)_156/(NP_156\NP_150)_156>) (<T NP\NP 0 2> (<L (NP\NP)/NP VBG VBG regarding (NP_124\NP_124)/NP_125>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ possible N_141/N_141>) (<T N 1 2> (<L N/N NN NN side N_134/N_134>) (<L N NNS NNS effects N>) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.20 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 1 2> (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ Our NP[nb]_188/N_188>) (<L N NN NN antibody N>) ) (<T S[dcl]\NP 1 2> (<L (S\NP)/(S\NP) RB RB specifically (S_181\NP_176)_181/(S_181\NP_176)_181>) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD killed (S[dcl]\NP_116)/NP_117>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ infected N_126/N_126>) (<L N NNS NNS cells N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN at ((S_140\NP_135)_140\(S_140\NP_135)_140)/NP_141>) (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_169/N_169>) (<T N 1 2> (<T N/N 1 2> (<L (N/N)/(N/N) RB RB very (N_164/N_158)_164/(N_164/N_158)_164>) (<L N/N JJ JJ low N_150/N_150>) ) (<L N NN NN dose N>) ) ) ) ) ) ) (<T S[dcl][conj] 1 2> (<L , , , , ,>) (<T S[dcl][conj] 1 2> (<L conj CC CC but conj>) (<T S[dcl] 1 2> (<L NP PRP PRP it NP>) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD can (S[dcl]\NP_197)/(S[b]_198\NP_197:B)_198>) (<L (S\NP)\(S\NP) RB RB also (S_210\NP_205)_210\(S_210\NP_205)_210>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB kill (S[b]\NP_217)/NP_218>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ other N_227/N_227>) (<L N NNS NNS cells N>) ) ) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 0 2> (<T S[dcl]\S[dcl] 0 2> (<L (S[dcl]\S[dcl])/NP VBD VBD said (S[dcl]\S[dcl]_94)/NP_95>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_104/N_104>) (<L N NNP NNP Yonehara N>) ) ) ) (<L . . . . .>) ) ) ) 
ID=wsj_1246.21 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L NP PRP PRP We NP>) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) VBP VBP do (S[dcl]\NP_134)/(S[b]_135\NP_134:B)_135>) (<L (S\NP)\(S\NP) RB RB n't (S_147\NP_142)_147\(S_147\NP_142)_147>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB know (S[b]\NP_154)/NP_155>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_162/N_162>) (<L N NN NN effect N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_170\NP_170)/NP_171>) (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ our NP[nb]_178/N_178>) (<L N NN NN antibody N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN on (NP_186\NP_186)/NP_187>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_201/N_201>) (<T N 1 2> (<L N/N JJ JJ human N_196/N_196>) (<L N NN NN body N>) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.22 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 0 2> (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP AIDS N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[pss]\NP) 0 2> (<L (S[dcl]\NP)/(S[pss]\NP) VBZ VBZ is (S[dcl]\NP_80)/(S[pss]_81\NP_80:B)_81>) (<L (S\NP)\(S\NP) RB RB n't (S_93\NP_88)_93\(S_93\NP_88)_93>) ) (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/NP VBN VBN considered (S[pss]\NP_100)/NP_101>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_115/N_115>) (<T N 1 2> (<L N/N JJ JJ widespread N_110/N_110>) (<L N NN NN problem N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_123\NP_123)/NP_124>) (<T NP 0 1> (<L N NNP NNP Japan N>) ) ) ) ) ) ) (<T S\S 0 2> (<T S\S 0 2> (<L (S\S)/S[dcl] : : -- (S_138\S_138)/S[dcl]_139>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_201/N_201>) (<L N NN NN government N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ reports (S[dcl]\NP_146)/NP_147>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<T N/N 1 2> (<L (N/N)/(N/N) IN IN about (N_177/N_171)_177/(N_177/N_171)_177>) (<L N/N CD CD 1,000 N_163/N_163>) ) (<T N 1 2> (<L N/N VBN VBN known N_156/N_156>) (<L N NNS NNS carriers N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_186\NP_186)/NP_187>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_194/N_194>) (<L N NN NN virus N>) ) ) ) ) ) ) (<L : : : -- :>) ) ) (<T S[dcl][conj] 1 2> (<L conj CC CC but conj>) (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ many N_346/N_346>) (<L N NNS NNS companies N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBP VBP have (S[dcl]\NP_212)/(S[pt]_213\NP_212:B)_213>) (<T S[pt]\NP 0 2> (<T S[pt]\NP 0 2> (<T S[pt]\NP 0 2> (<T S[pt]\NP 0 2> (<T (S[pt]\NP)/PP 0 2> (<L ((S[pt]\NP)/PP)/NP VBN VBN poured ((S[pt]\NP_222)/PP_223)/NP_224>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ substantial N_233/N_233>) (<L N NNS NNS resources N>) ) ) ) (<T PP 0 2> (<L PP/NP IN IN into PP/NP_239>) (<T NP 0 1> (<L N NN NN research N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_255\NP_250)_255\(S_255\NP_250)_255)/NP_256>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ recent N_265/N_265>) (<L N NNS NNS years N>) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 1> (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/(S[to]\NP) VBG VBG hoping (S[ng]\NP_277)/(S[to]_278\NP_277:B)_278>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_287)/(S[b]_288\NP_287:B)_288>) (<T S[b]\NP 0 2> (<T (S[b]\NP)/PP 0 2> (<L (S[b]\NP)/PP VB VB cash (S[b]\NP_295)/PP_296>) (<L (S\NP)\(S\NP) RP RP in (S_308\NP_303)_308\(S_308\NP_303)_308>) ) (<T PP 0 2> (<L PP/NP IN IN on PP/NP_313>) (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_327/N_327>) (<T N 1 2> (<L N/N JJ JJ possible N_322/N_322>) (<L N NN NN cure N>) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.23 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_440/N_440>) (<L N NNP NNP Kitamura N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_241)/S[dcl]_242>) (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<T N/N 1 2> (<L (N/N)/(N/N) IN IN about (N_310/N_304)_310/(N_310/N_304)_310>) (<L N/N CD CD 35 N_296/N_296>) ) (<L N NNS NNS projects N>) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/PP 0 2> (<L (S[dcl]\NP)/PP VBP VBP are (S[dcl]\NP_249)/PP_250>) (<L (S\NP)\(S\NP) RB RB currently (S_262\NP_257)_262\(S_262\NP_257)_262>) ) (<T PP 0 2> (<L PP/NP IN IN under PP/NP_267>) (<T NP 0 1> (<L N NN NN way N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_283\NP_278)_283\(S_283\NP_278)_283)/NP_284>) (<T NP 0 1> (<L N NNP NNP Japan N>) ) ) ) ) (<T S[dcl][conj] 1 2> (<L , , , , ,>) (<T S[dcl][conj] 1 2> (<L conj CC CC and conj>) (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_316>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ Japanese N_403/N_403>) (<L N NNS NNS researchers N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_412\NP_412)/NP_413>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_427/N_427>) (<T N 1 2> (<L N/N JJ JJ past N_422/N_422>) (<L N NN NN year N>) ) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBP VBP have (S[dcl]\NP_325)/(S[pt]_326\NP_325:B)_326>) (<T S[pt]\NP 0 2> (<L (S[pt]\NP)/S[adj] VBN VBN made (S[pt]\NP_333)/S[adj]_334>) (<T S[adj] 0 2> (<T S[adj] 0 2> (<T S[adj] 0 2> (<L S[adj]/NP JJ JJ available S[adj]/NP_339>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD three N_355/N_355>) (<T N 1 2> (<L N/N JJ JJ possible N_348/N_348>) (<L N NNS NNS cures N>) ) ) ) ) (<T S[adj]\S[adj] 0 2> (<L (S[adj]\S[adj])/NP TO TO to (S[adj]_364\S[adj]_364)/NP_365>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ American N_374/N_374>) (<L N NNS NNS researchers N>) ) ) ) ) (<T S[adj]\S[adj] 0 2> (<L (S[adj]\S[adj])/NP IN IN for (S[adj]_383\S[adj]_383)/NP_384>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ clinical N_393/N_393>) (<L N NNS NNS tests N>) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.24 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L NP PRP PRP He NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[em] VBD VBD said (S[dcl]\NP_185)/S[em]_186>) (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_191>) (<T S[dcl] 1 2> (<T S/S 0 2> (<L (S/S)/S[dcl] WRB WRB when (S_300/S_300)/S[dcl]_301>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS scientists N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN from (NP_370\NP_370)/NP_371>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_385/N_385>) (<T N 1 2> (<L N/N CD CD two N_380/N_380>) (<L N NNS NNS countries N>) ) ) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBP VBP meet S[dcl]\NP_306>) (<L (S\NP)\(S\NP) RB RB again (S_318\NP_313)_318\(S_318\NP_313)_318>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_331\NP_326)_331\(S_331\NP_326)_331)/NP_332>) (<T NP 0 1> (<L N NNP NNP January N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_348\NP_343)_348\(S_348\NP_343)_348)/NP_349>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP New N_358/N_358>) (<L N NNP NNP Orleans N>) ) ) ) ) ) ) (<T S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_290/N_290>) (<L N NNP NNP Japanese N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD will (S[dcl]\NP_200)/(S[b]_201\NP_200:B)_201>) (<T S[b]\NP 0 2> (<T (S[b]\NP)/PP 0 2> (<L ((S[b]\NP)/PP)/NP VB VB present ((S[b]\NP_210)/PP_211)/NP_212>) (<T NP 0 1> (<T N 1 2> (<T N/N 1 2> (<T (N/N)/(N/N) 1 2> (<T ((N/N)/(N/N))/((N/N)/(N/N)) 0 2> (<L (((N/N)/(N/N))/((N/N)/(N/N)))/(S[asup]\NP) IN IN at (((N_261/N_248)_261/(N_250/N_251)_249)_261/((N_261/N_248)_261/(N_250/N_251)_249)_261)/(S[asup]_262\NP_254)_262>) (<L S[asup]\NP JJS JJS least S[asup]\NP_267>) ) (<L (N/N)/(N/N) CD CD three (N_235/N_229)_235/(N_235/N_229)_235>) ) (<L N/N JJR JJR more N_221/N_221>) ) (<L N NNS NNS drugs N>) ) ) ) (<T PP 0 2> (<L PP/NP IN IN for PP/NP_273>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ human N_282/N_282>) (<L N NN NN testing N>) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.25 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP AZT N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ is (S[dcl]\NP_189)/NP_190>) (<T NP 0 2> (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_221/N_221>) (<L N NN NN world N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_213/N_213)\NP_214>) ) (<T N 1 2> (<L N/N JJ JJ only N_206/N_206>) (<T N 1 2> (<L N/N NN NN prescription N_199/N_199>) (<L N NN NN medicine N>) ) ) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/PP VBN VBN approved (S[pss]\NP_228)/PP_229>) (<T PP 0 2> (<L PP/(S[ng]\NP) IN IN for PP/(S[ng]_236\NP_234)_236>) (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/NP VBG VBG treating (S[ng]\NP_243)/NP_244>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_251/N_251>) (<L N NN NN disease N>) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.26 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Wellcome N_116/N_116>) (<L N NNP NNP PLC N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_145/N_145>) (<T N 1 2> (<L N/N JJ JJ major N_140/N_140>) (<T N 1 2> (<L N/N JJ JJ British N_133/N_133>) (<T N 1 2> (<L N/N NN NN pharmaceutical N_126/N_126>) (<L N NN NN maker N>) ) ) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ sells (S[dcl]\NP_71)/NP_72>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_79/N_79>) (<L N NN NN drug N>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN under ((S_92\NP_87)_92\(S_92\NP_87)_92)/NP_93>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_107/N_107>) (<T N 1 2> (<L N/N NN NN name N_102/N_102>) (<L N NNP NNP Retrovir N>) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.27 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT A NP[nb]_155/N_155>) (<T N 1 2> (<L N/N NNP NNP Wellcome N_150/N_150>) (<L N NN NN spokesman N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[to]\NP) VBD VBD declined (S[dcl]\NP_82)/(S[to]_83\NP_82:B)_83>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_92)/(S[b]_93\NP_92:B)_93>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/PP VB VB comment (S[b]\NP_100)/PP_101>) (<T PP 0 2> (<L PP/NP IN IN on PP/NP_106>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_113/N_113>) (<L N NN NN discovery N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_121\NP_121)/NP_122>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_129/N_129>) (<L N NN NN antibody N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_137\NP_137)/NP_138>) (<T NP 0 1> (<L N NNP NNP Japan N>) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1246.28 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L S/S CC CC But S_287/S_287>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Andrew N_223/N_223>) (<L N NNP NNP Porter N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_238/N_238>) (<T N 1 2> (<L N/N NN NN drug-industry N_233/N_233>) (<L N NN NN analyst N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN at (NP_246\NP_246)/NP_247>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Nikko N_263/N_263>) (<T N 1 2> (<L N/N NNPS NNPS Securities N_256/N_256>) (<L N NNP NNP Co. N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_272\NP_272)/NP_273>) (<T NP 0 1> (<L N NNP NNP London N>) ) ) ) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_81)/S[dcl]_82>) (<T S[dcl] 1 2> (<T S/S 0 2> (<L (S/S)/S[dcl] IN IN if (S_159/S_159)/S[dcl]_160>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_214/N_214>) (<L N NN NN product N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[to]\NP) VBD VBD were (S[dcl]\NP_169)/(S[to]_170\NP_169:B)_170>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_179)/(S[b]_180\NP_179:B)_180>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[pss]\NP) VB VB be (S[b]\NP_189)/(S[pss]_190\NP_189:B)_190>) (<T S[pss]\NP 1 2> (<L (S\NP)/(S\NP) RB RB successfully (S_207\NP_202)_207/(S_207\NP_202)_207>) (<L S[pss]\NP VBN VBN developed S[pss]\NP_195>) ) ) ) ) ) ) (<T S[dcl] 1 2> (<L NP PRP PRP it NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD would (S[dcl]\NP_91)/(S[b]_92\NP_91:B)_92>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB represent (S[b]\NP_99)/NP_100>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_114/N_114>) (<T N 1 2> (<L N/N JJ JJ potential N_109/N_109>) (<L N NN NN threat N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP TO TO to (NP_122\NP_122)/NP_123>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_137/N_137>) (<T N 1 2> (<L N/N JJ JJ long-term N_132/N_132>) (<L N NN NN viability N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_145\NP_145)/NP_146>) (<T NP 0 1> (<L N NNP NNP Retrovir N>) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
